Search results
Results from the WOW.Com Content Network
Metformin, an oral type 2 diabetes medicine, may lead to a modest weight loss and does not usually lead to significant, if any, weight gain. In various clinical studies, when metformin was used alone, it led to a weight loss of 0.7 to 3.8 kg (1.5 to 8.4 lbs) in most patients, but other studies have shown weight loss up to 5.8 kg (12.8 lbs).
Metformin belongs to the class of drugs known as biguanides. 2. Upsides. Metformin is used to treat type 2 diabetes and is the preferred therapy for people with type 2 diabetes who do not have any contraindications to using metformin (such as kidney disease, metabolic acidosis, or poor liver function). It may be used in combination with other ...
Metformin, an oral type 2 diabetes medicine, may lead to a modest weight loss and does not usually lead to significant, if any, weight gain. In various clinical studies, when metformin was used alone, it led to a weight loss of 0.7 to 3.8 kg (1.5 to 8.4 lbs) in most patients, but other studies have shown weight loss up to 5.8 kg (12.8 lbs).
Metformin and sitagliptin is a combination medicine that is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. metformin and sitagliptin is not for treating type 1 diabetes. Metformin and sitagliptin may also be used for purposes not listed in this medication guide.
Metformin hydrochloride tablets are prescription medicines that contain metformin hydrochloride. Metformin hydrochloride tablets are used with diet and exercise to help control high blood sugar (hyperglycemia) in adults with type 2 diabetes. Metformin hydrochloride tablets are not for people with type 1 diabetes.
May be used in combination with a glucagon-like peptide-1 (GLP-1) agonist, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, a dipeptidyl peptidase-4 (DPP-4) inhibitor, a thiazolidinedione antidiabetic agent, a sulfonylurea, or a meglitinide (repaglinide, nateglinide) for the management of type 2 diabetes mellitus in patients who do not ...
The chance may be raised when this medicine (metformin extended-release tablets) is used with other drugs for diabetes. Signs may be dizziness, headache, feeling sleepy or weak, shaking, fast heartbeat, confusion, hunger, or sweating. Call your doctor right away if you have any of these signs.
Metformin, an oral type 2 diabetes medicine, may lead to a modest weight loss and does not usually lead to significant, if any, weight gain. In various clinical studies, when metformin was used alone, it led to a weight loss of 0.7 to 3.8 kg (1.5 to 8.4 lbs) in patients. Many clinicians consider metformin a "weight neutral" treatment, meaning ...
What is glipizide and metformin? Glipizide and metformin is a combination of two oral diabetes medicines that help control blood sugar levels. Glipizide and metformin is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes. glipizide and metformin is not for treating type 1 diabetes.
Risk factors for metformin-associated lactic acidosis include with renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery, and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive ...